Results 61 to 70 of about 17,345 (219)
INTRODUCTION: Dysgeusia is a common but often underrecognized complication of chemotherapy that canreduce nutritional intake and body weight, impair quality of life (QoL), and compromise treatment adherence.The aim of this study was to describe the ...
Julianna Dąbrowa +3 more
doaj +1 more source
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden +10 more
wiley +1 more source
Oral Toxicities Associated with Immune Checkpoint Inhibitors: Meta-Analyses of Clinical Trials [PDF]
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment; however, their oral toxicity profile is not well elucidated. This review aimed to investigate the prevalence of oral toxicities including xerostomia, mucositis/stomatitis ...
Akanksha Srivastava +6 more
doaj +1 more source
A Cross‐Sectional Study of Patient Views on Acceptability of Olfactory Implants
ABSTRACT Objectives Unlike other chronic conditions, effective therapies for smell and taste disorders (SATDs) remain scarce. Olfactory implants are an emerging area of therapy aimed at restoring the sense of smell through electrical stimulation of the olfactory pathway.
Gabija Klyvyte +9 more
wiley +1 more source
Mirtazapine Therapy for Dysgeusia in an Elderly Patient [PDF]
Sir: Taste disturbances are common among the elderly and can present in up to 11% of elderly persons taking multiple medications.1 Dysgeusia was present in 38% of 196 cases of taste complaints in one study.2 Changes in physiology, systemic medical illnesses, infections, dental problems, and multiple medications have been shown to cause taste ...
Kalpana P, Padala +2 more
openaire +2 more sources
Abstract Objectives/Background The introduction of calcitonin gene‐related peptide antagonists has transformed migraine care. Zavegepant, a third‐generation intranasal gepant, offers a nonoral treatment option for acute migraine. Although clinical trials support its efficacy and safety, real‐world data are limited.
Eric Dunn +5 more
wiley +1 more source
Persistent dysgeusia post-halitosis treatment : how does it impact the patients? quality of life? [PDF]
The objective of this study was to evaluate the quality of life and the presence of anxiety and depression in patients with dysgeusia post halitosis treatment.
Nicodemo, Denise +10 more
core +1 more source
Associations of the number and pattern (latent-class analysis) of acute COVID-19 symptoms with any chronic COVID-19 symptom, particularly chronic fatigue, anosmia and dysgeusia.
Jason Zimmerman (13200084) +13 more
core +1 more source
ABSTRACT Background and Aim Although clarithromycin resistance is a major cause of empirical triple therapy failure for Helicobacter pylori eradication, the clinical relevance of amoxicillin susceptibility remains uncertain. We first compared eradication outcomes between empirical and susceptibility‐guided tailored triple therapy and then evaluated the
Hoyoung Wang +10 more
wiley +1 more source
This is a review of multiple pathologic conditions associated with altered taste perception and identification. We stated the steps and the molecular basis of this sense. This paper includes two cases that exemplify two distinct types of dysgeusia; case, 1 a 48 year old man who had clinical manifestations of hypogeusia and dysgeusia for one year ...
J A, Tamayo y Orozco, A A, Cario
openaire +1 more source

